Log In
BCIQ
Print this Print this
 

NP201

  Manage Alerts
Collapse Summary General Information
Company NGM Biopharmaceuticals Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$94.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/23/2015

Undisclosed

$94.0M

Undisclosed

Get a free BioCentury trial today